161 related articles for article (PubMed ID: 14670006)
1. Protein hydroperoxides are a major product of low density lipoprotein oxidation during copper, peroxyl radical and macrophage-mediated oxidation.
Gieseg SP; Pearson J; Firth CA
Free Radic Res; 2003 Sep; 37(9):983-91. PubMed ID: 14670006
[TBL] [Abstract][Full Text] [Related]
2. Macrophage mediated protein hydroperoxide formation and lipid oxidation in low density lipoprotein are inhibited by the inflammation marker 7,8-dihydroneopterin.
Firth CA; Crone EM; Flavall EA; Roake JA; Gieseg SP
Biochim Biophys Acta; 2008 Jun; 1783(6):1095-101. PubMed ID: 18342632
[TBL] [Abstract][Full Text] [Related]
3. Effects of ebselen and probucol on oxidative modifications of lipid and protein of low density lipoprotein induced by free radicals.
Noguchi N; Gotoh N; Niki E
Biochim Biophys Acta; 1994 Jul; 1213(2):176-82. PubMed ID: 8025128
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein oxidation in the absence of lipid peroxidation enhances LDL uptake by macrophages.
Hunt JV; Bailey JR; Schultz DL; McKay AG; Mitchinson MJ
FEBS Lett; 1994 Aug; 349(3):375-9. PubMed ID: 8050600
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the kinetics of low-density lipoprotein oxidation initiated by copper or by azobis (2-amidinopropane).
Thomas MJ; Chen Q; Franklin C; Rudel LL
Free Radic Biol Med; 1997; 23(6):927-35. PubMed ID: 9378372
[TBL] [Abstract][Full Text] [Related]
6. A critical overview of the chemistry of copper-dependent low density lipoprotein oxidation: roles of lipid hydroperoxides, alpha-tocopherol, thiols, and ceruloplasmin.
Burkitt MJ
Arch Biochem Biophys; 2001 Oct; 394(1):117-35. PubMed ID: 11566034
[TBL] [Abstract][Full Text] [Related]
7. Lipid oxidation predominates over protein hydroperoxide formation in human monocyte-derived macrophages exposed to aqueous peroxyl radicals.
Firth CA; Yang YT; Gieseg SP
Free Radic Res; 2007 Jul; 41(7):839-48. PubMed ID: 17577745
[TBL] [Abstract][Full Text] [Related]
8. The antioxidative effects of the isoflavan glabridin on endogenous constituents of LDL during its oxidation.
Belinky PA; Aviram M; Fuhrman B; Rosenblat M; Vaya J
Atherosclerosis; 1998 Mar; 137(1):49-61. PubMed ID: 9568736
[TBL] [Abstract][Full Text] [Related]
9. Free and peptide-bound DOPA can inhibit initiation of low density lipoprotein oxidation.
Exner M; Hermann M; Hofbauer R; Kapiotis S; Gmeiner BM
Free Radic Res; 2003 Nov; 37(11):1147-56. PubMed ID: 14703726
[TBL] [Abstract][Full Text] [Related]
10. Thyroid hormone (T3) and its acetic derivative (TA3) protect low-density lipoproteins from oxidation by different mechanisms.
Faure P; Oziol L; Artur Y; Chomard P
Biochimie; 2004 Jun; 86(6):411-8. PubMed ID: 15283976
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of lipid peroxidation in mixtures of HDL and LDL, mutual effects.
Raveh O; Pinchuk I; Fainaru M; Lichtenberg D
Free Radic Biol Med; 2001 Dec; 31(11):1486-97. PubMed ID: 11728821
[TBL] [Abstract][Full Text] [Related]
12. Low-density lipoprotein is the major carrier of lipid hydroperoxides in plasma. Relevance to determination of total plasma lipid hydroperoxide concentrations.
Nourooz-Zadeh J; Tajaddini-Sarmadi J; Ling KL; Wolff SP
Biochem J; 1996 Feb; 313 ( Pt 3)(Pt 3):781-6. PubMed ID: 8611155
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of peroxyl radical-mediated lipid oxidation by plasmalogen phospholipids and alpha-tocopherol.
Hahnel D; Beyer K; Engelmann B
Free Radic Biol Med; 1999 Nov; 27(9-10):1087-94. PubMed ID: 10569641
[TBL] [Abstract][Full Text] [Related]
14. When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid.
Bagnati M; Perugini C; Cau C; Bordone R; Albano E; Bellomo G
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):143-52. PubMed ID: 10229669
[TBL] [Abstract][Full Text] [Related]
15. Comparative time-courses of copper-ion-mediated protein and lipid oxidation in low-density lipoprotein.
Knott HM; Baoutina A; Davies MJ; Dean RT
Arch Biochem Biophys; 2002 Apr; 400(2):223-32. PubMed ID: 12054433
[TBL] [Abstract][Full Text] [Related]
16. 7,8 Dihydroneopterin inhibits low density lipoprotein oxidation in vitro. Evidence that this macrophage secreted pteridine is an anti-oxidant.
Gieseg SP; Reibnegger G; Wachter H; Esterbauer H
Free Radic Res; 1995 Aug; 23(2):123-36. PubMed ID: 7581810
[TBL] [Abstract][Full Text] [Related]
17. Lipid hydroperoxide involvement in copper-dependent and independent oxidation of low density lipoproteins.
Thomas CE; Jackson RL
J Pharmacol Exp Ther; 1991 Mar; 256(3):1182-8. PubMed ID: 2005580
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the oxidative modification of LDL by nitecapone.
Pentikäinen MO; Lindstedt KA; Kovanen PT
Arterioscler Thromb Vasc Biol; 1995 Jun; 15(6):740-7. PubMed ID: 7773727
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein B carbonyl formation is enhanced by lipid peroxidation during copper-mediated oxidation of human low-density lipoproteins.
Yan LJ; Lodge JK; Traber MG; Packer L
Arch Biochem Biophys; 1997 Mar; 339(1):165-71. PubMed ID: 9056246
[TBL] [Abstract][Full Text] [Related]
20. Effects of methyl 9(or 10)-hydroxy-10(or 9)-mercaptostearate and hexadecanethioic S-acid on cupric ion- or 2,2-azo-bis(2-amidinopropane) dihydrochloride (AAPH)-induced oxidation of low density lipoprotein.
Tanaka M; Takada K; Higuchi T; Nakagawa M; Murase M; Tobinaga S
Biol Pharm Bull; 1996 May; 19(5):692-6. PubMed ID: 8741576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
